Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Circulation|November 1, 1994
Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosisF S Markland, G S Friedrichs, S R Pewitt, et al.
European Journal of Pharmacology|June 13, 1996
5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac deathG S Friedrichs, J N Abreu, S C Black, et al.
Journal of Molecular and Cellular Cardiology|December 1, 1993
Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamideS C Black, S O Fagbemi, L Chi, et al.
The American Journal of Cardiology|November 26, 1993
Antiarrhythmic versus antifibrillatory actions: inference from experimental studiesB R Lucchesi, L Chi, G S Friedrichs, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heartG S Friedrichs, L Chi, S C Black, et al.
The American Journal of Physiology|October 1, 1994
Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenationL Chi, G S Friedrichs, J Y Oh, et al.
Journal of Cardiovascular Pharmacology|February 10, 1998
Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillationG S Friedrichs, J N Abreu, E M Driscoll, et al.
Circulation Research|October 1, 1994
Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heartG S Friedrichs, K S Kilgore, P J Manley, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channelsG S Friedrichs, L Chi, S C Black, et al.
Cardiovascular Research|May 1, 1995
Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injuryS C Black, M R Gralinski, G S Friedrichs, et al.
Pageof 3